Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

NCT04522544

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Universitätsklinikum Bonn Bonn, Germany

Universitätsklinikum Köln Cologne, Germany

Universitätsklinikum Essen Essen, Germany

Universitätsmedizin Göttingen Göttingen, Germany

View Trial Details

Active, Not Recruiting

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
Locations: University of California San Diego La Jolla, California, United States

UCSF Benioff Children's Hospital San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States

View all 26 locations

View Trial Details

Active, Not Recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

AOA-HOPE Tucson, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

HOAG Memorial Hospital Presbyterian Newport, California, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

NCT03991832

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

NCT03110978

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +32 more
Locations: MD Anderson in The Woodlands Conroe, Texas, United States

M D Anderson Cancer Center Houston, Texas, United States

MD Anderson West Houston Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Screening for Chronic Liver Diseases in General Population

NCT06366425

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: CHU de Montpellier Montpellier, France

View Trial Details

Active, Not Recruiting

Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial

NCT04727307

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU Amiens Amiens, France

CHU d'Angers Angers, France

Hôpital Jean Verdier Bondy, France

Hôpital Beaujon Clichy, France

View all 19 locations

View Trial Details

Active, Not Recruiting

Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI

NCT07658105

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

NCT04616248

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

NCT04090710

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Peter MacCallum Cancer Centre Melbourne, Australia

Cross Cancer Institute Edmonton, Alberta, Canada

Juravinski Cancer Centre Hamilton, Ontario, Canada

Grand River Regional Cancer Centre Kitchener, Ontario, Canada

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions